Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
Behnam Ahmadian Baghbaderani
The industry must overcome enormous challenges in order to take the next steps in induced pluripotent stem cell technology.
How to drive antibody drug development and manufacture forward safely and quickly.
Gene therapy manufacturers will need to focus on upstream filtration to minimize the risk of viral infection.
In December, The Medicine Maker will showcase the top technologies to have been released throughout 2020. Nominations are now open.
Advanced medicine companies are shifting their focus to off-the-shelf approaches, solid tumors, and combinations with immune checkpoint modulators.
Cytiva’s KUBio box modular environment for Viral Vectors took the top spot in The Medicine Maker 2019 Innovation Awards. Find out why.
In under two months, the ISCT managed to pull together a gamified virtual conference platform.
Gene therapies look set to revolutionize the field of medicine – and AAVs have emerged as the vector of choice.
Why finding new talent is crucial to the success of the cell and gene therapy industry.
Experts from the UK discuss how the country is tackling the CGT skills gap.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.